GQ1010
NSCLC, TNBC, other solid tumors
Preclinical/Phase 1Partnered (Pyramid Biosciences)
Key Facts
Indication
NSCLC, TNBC, other solid tumors
Phase
Preclinical/Phase 1
Status
Partnered (Pyramid Biosciences)
Company
About GeneQuantum
A global leader in ADC technology, developing next-generation bioconjugate therapeutics with proprietary enzymatic conjugation platforms.
View full company profile